MedPath

effect of interapitonial bupivacaine on postoperative pai

Phase 2
Conditions
Morbid Obesity.
Other obesity
Registration Number
IRCT20140109016151N6
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

patients undergoing laparoscopic bariatric surgery with BMI>40 .
With age 17-60 years.
ASA 2.

Exclusion Criteria

patients with history of analgesics (narcotic or non-narcotic) 24 hours before surgery.
Drug or alcohol abuse or allergy to any of the drugs used in the study.
Chronic pain syndrome.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: 2, 8 and 24 hours after surgery. Method of measurement: based on a visual scale VAS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath